Kiniksa Pharmaceuticals International, plc Operating Lease Right-of-Use Assets
Kiniksa Pharmaceuticals International, plc (KNSA) had Operating Lease Right-of-Use Assets of $9.33 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-04-28
- 2026-03-31: Operating Lease, Right-of-Use Asset $9.33M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $9.81M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $10.07M.
- 2025-06-30: Operating Lease, Right-of-Use Asset $10.30M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-03-31 | $9.33M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $9.81M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $10.07M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $10.30M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $10.45M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $10.38M 10-K · filed 2026-02-24 |
| 2024-09-30 | $11.10M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $11.78M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $12.32M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $11.93M 10-K · filed 2025-02-25 |
| 2023-09-30 | $12.67M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $13.19M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $5.23M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $5.38M 10-K · filed 2024-02-28 |
| 2022-09-30 | $6.17M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.07M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.82M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $5.55M 10-K · filed 2023-03-02 |
| 2021-09-30 | $6.13M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.39M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5.98M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $6.57M 10-K · filed 2022-02-24 |
| 2020-09-30 | $1.17M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.32M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $1.63M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $1.93M 10-K · filed 2021-02-25 |
| 2019-09-30 | $2.22M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $2.50M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $3.35M 10-Q · filed 2019-05-07 |
| 2019-01-01 | $3.68M 10-Q · filed 2019-11-05 |